EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

GLP-1 receptor agonists: exploration of transformation from metabolic regulation to multi-organ therapy

Bing Gong, Couwen Li, Zhuang'e Shi, FuPing Wang, Ruanxian Dai, Guobing Chen, Heng Su

Frontiers in Pharmacology · 11.09.2025 · 16

DOI: 10.3389/fphar.2025.1675552 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 11.09.2025. Verfasst von Bing Gong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, China. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for type 2 diabetes and obesity, have evolved into multi-organ potential therapeutics due to their pleiotropic effects beyond glycemic control. Mechanistically, GLP-1 signaling modulates immune and inflammatory pathways, regulates autophagy and pyroptosis, alleviates endoplasmic reticulum stress, and interacts with the gut microbiome. These pleiotropic effects provide a rationale for exploring their role in multiple organ systems. Clinical trials have demonstrated cardiovascular and renal protection, leading to additional approvals in high-risk populations. Early data also suggest potential benefits in liver disease, obstructive sleep apnea, chronic respiratory disorders, neurodegenerative and psychiatric conditions, reproductive dysfunction, obesity-associated cancers, and sepsis, although these remain investigational. Therefore, this review aims to synthesize the evidence on the mechanistic expansion of GLP-1RAs from metabolic regulators to systemic modulators of inflammation, autophagy, and organ protection, and explores their therapeutic repurposing across diseases.

Schlagwörter

Stichwörter der Autor:innen

GLP-1 receptor agonistgut microbiotamolecular mechanismsmulti-organ protectiontherapeutic repurposing

Autor:innen und Institutionen

  • Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, China.
  • Medical School, Kunming University of Science and Technology, Kunming, China.
  • Department of Emergency Medicine, The First People's Hospital of Yunnan Province, Kunming, China.
  • The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.

Zitieren

APA

Gong, B., Li, C., Shi, Z., Wang, F., Dai, R., Chen, G., & Su, H. (2025). GLP-1 receptor agonists: exploration of transformation from metabolic regulation to multi-organ therapy. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1675552

Vancouver

Gong B, Li C, Shi Z, Wang F, Dai R, Chen G, et al. GLP-1 receptor agonists: exploration of transformation from metabolic regulation to multi-organ therapy. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1675552

BibTeX
@article{Gong2025,
  author = {Gong, Bing and Li, Couwen and Shi, Zhuang'e and Wang, FuPing and Dai, Ruanxian and Chen, Guobing and Su, Heng},
  title = {GLP-1 receptor agonists: exploration of transformation from metabolic regulation to multi-organ therapy},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1675552}
}
Kostenlos starten →